August 13, 2026 In the News Commentary: Fix the Market Challenges Behind Microbiome-Sparing Antibiotics Read More +
August 6, 2026 In the News Vedanta Biosciences Secures New Funding to Advance Phase 3 Program Read More +
July 16, 2026 In the News Trellis Bioscience Raises $9 Million to Advance Phase 2 Trial of mAb for PJIs Read More +
July 14, 2026 In the News The need for innovative financing models for antimicrobial development Read More +
July 1, 2026 In the News Telum Therapeutics raises €18 million to advance treatments for hospital-acquired infections Read More +
